Related Experiment Video
Updated: Dec 1, 2025
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.5K
Medical anti-glaucoma therapy: Beyond the drop
Paul E Miller1, Joshua Seth Eaton1
1School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Veterinary Ophthalmology
|November 9, 2020
Summary
New sustained-release therapies aim to overcome challenges in glaucoma treatment, offering alternatives to traditional eye drops. These innovative approaches include implants, gene therapy, and stem cells for better intraocular pressure control.
Area of Science:
- Ophthalmology
- Drug Delivery Systems
- Regenerative Medicine
Background:
- Traditional glaucoma treatment relies on eye drops, facing challenges in sustained intraocular pressure (IOP) control and patient adherence.
- Difficulties in maintaining consistent IOP and adherence to anti-glaucoma drop regimens necessitate novel therapeutic strategies.
Purpose of the Study:
- To review emerging anti-glaucoma therapies designed for sustained drug delivery and improved patient outcomes.
- To explore innovative treatment modalities that address the limitations of current topical anti-glaucoma medications.
Main Methods:
- Review of novel sustained-release technologies, including intracameral devices, implants, and topical formulations of prostaglandin analogs.
- Exploration of advanced therapeutic approaches such as gene therapy (viral vectors, CRISPR, siRNA), stem cell technology, nanotechnology, and nasal sprays.
- Investigation of non-invasive stimulation techniques for optic nerve health.
Main Results:
- Multiple sustained-delivery systems for prostaglandin analogs are in clinical trials, including intracameral implants and conjunctival rings.
- Gene therapy offers potential for correcting genetic defects and modulating ocular conditions. Stem cell therapies and nanotechnology present unique drug delivery avenues.
- Emerging modalities like nasal sprays and non-invasive nerve stimulation are being developed to directly target optic nerve health.
Conclusions:
- Various novel sustained-release drug delivery systems and advanced therapeutic modalities are poised to transform glaucoma management.
- These innovative treatments, including implants, gene therapy, and stem cells, are expected to offer significant advantages over conventional eye drops.
- The future of medical glaucoma treatment, particularly in veterinary medicine, is likely to shift towards these advanced, sustained-effect therapies.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
849
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
849
01:28Angle Closure Glaucoma: Treatment
974
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
974
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
01:22Drug Delivery: Miscellaneous Routes
617
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
617
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.4K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.4K